Robert Evans, a doctor of pharmacy, has been appointed vice president of clinical sciences at Tiziana Life Sciences Plc, a UK-based oncology company. Dr Evans was previously head of clinical development at Glenmark Pharmaceuticals Inc and before that a senior scientist in the immunology and inflammation group at Regeneron Pharmaceuticals Inc.
Dr Evans received a Bachelor of Science in pharmacy from the University of Illinois and a PharmD from the University of Kansas City, Kansas, both in the US.
Tiziana announced the appointment on 4 May 2016.
Copyright 2016 Evernow Publishing Ltd